Clinical trial

IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin…

NCT00200681 · Nantes University Hospital, Other · Completed

Key facts

NCT number NCT00200681
Title IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
Official title Etude Multicentrique Ouverte Randomisée de Phase III Comparant l'Association de VELCADE®-Dexaméthasone à la Chimiothérapie de Type VAD Pour le Traitement Des Patients Porteurs de Myélome Multiple de Novo Jusqu'à l'âge de 65 Ans
Lead sponsor Nantes University Hospital, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Multiple Myeloma
Intervention type Drug
Interventions Velcade
Enrollment 493
Start date Jun 1, 2005
Primary completion Jan 1, 2008
Completion Jun 1, 2008
First posted Sep 20, 2005
Last update posted Feb 5, 2009
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies